Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24207733 | 0.83 | — | — | |
| SCHEMBL19860207 | 0.81 | L3MBTL1 (0.36) | L3MBTL1MAPT | |
| SCHEMBL19859960 | 0.80 | L3MBTL1 (0.36) | L3MBTL1MAPT | |
| SCHEMBL22652618 | 0.78 | L3MBTL1 (0.34) | L3MBTL1MAPT | |
| SCHEMBL19422849 | 0.77 | L3MBTL1 (0.38) | L3MBTL1MAPT | |
| SCHEMBL22652630 | 0.76 | MAPK1 (0.44) | — | |
| SCHEMBL14260217 | 0.75 | MEN1 (0.46) | L3MBTL1 | |
| SCHEMBL21572115 | 0.75 | L3MBTL1 (0.36) | L3MBTL1MAPT | |
| SCHEMBL19187678 | 0.75 | AMY2A (0.37) | L3MBTL1MAPT | |
| SCHEMBL20746624 | 0.74 | L3MBTL1 (0.38) | L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220017646-A1 | METHODS AND COMPOSITIONS FOR ACHIEVING HEMOSTASIS AND STABLE BLOOD CLOT FORMATION | ENDOMEDIX, INC. | 2022-01-20 | — | — | US | disclosed |
| US-11033654-B2 | Methods and compositions for achieving hemostasis and stable blood clot formation | ENDOMEDIX, INC. (US) | 2021-06-15 | — | — | US | disclosed |
| US-20200353121-A1 | METHODS AND COMPOSITIONS FOR ACHIEVING HEMOSTASIS AND STABLE BLOOD CLOT FORMATION | ENDOMEDIX, INC. | 2020-11-12 | — | — | US | disclosed |